Zimmer Biomet Holdings Stock Market Value
| ZBH Stock | USD 86.60 0.94 1.07% |
| Symbol | Zimmer |
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Zimmer Biomet. If investors know Zimmer will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Zimmer Biomet listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.06) | Dividend Share 0.96 | Earnings Share 4.03 | Revenue Per Share | Quarterly Revenue Growth 0.097 |
The market value of Zimmer Biomet Holdings is measured differently than its book value, which is the value of Zimmer that is recorded on the company's balance sheet. Investors also form their own opinion of Zimmer Biomet's value that differs from its market value or its book value, called intrinsic value, which is Zimmer Biomet's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Zimmer Biomet's market value can be influenced by many factors that don't directly affect Zimmer Biomet's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Zimmer Biomet's value and its price as these two are different measures arrived at by different means. Investors typically determine if Zimmer Biomet is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Zimmer Biomet's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Zimmer Biomet 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Zimmer Biomet's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Zimmer Biomet.
| 10/28/2025 |
| 01/26/2026 |
If you would invest 0.00 in Zimmer Biomet on October 28, 2025 and sell it all today you would earn a total of 0.00 from holding Zimmer Biomet Holdings or generate 0.0% return on investment in Zimmer Biomet over 90 days. Zimmer Biomet is related to or competes with Smith Nephew, Quest Diagnostics, STERIS Plc, Waters, Illumina, West Pharmaceutical, and DexCom. Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates in the musculoskeletal healthcare business in the... More
Zimmer Biomet Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Zimmer Biomet's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Zimmer Biomet Holdings upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.13) | |||
| Maximum Drawdown | 18.45 | |||
| Value At Risk | (2.20) | |||
| Potential Upside | 2.92 |
Zimmer Biomet Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Zimmer Biomet's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Zimmer Biomet's standard deviation. In reality, there are many statistical measures that can use Zimmer Biomet historical prices to predict the future Zimmer Biomet's volatility.| Risk Adjusted Performance | (0.06) | |||
| Jensen Alpha | (0.27) | |||
| Total Risk Alpha | (0.45) | |||
| Treynor Ratio | (0.43) |
Zimmer Biomet January 26, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.06) | |||
| Market Risk Adjusted Performance | (0.42) | |||
| Mean Deviation | 1.29 | |||
| Coefficient Of Variation | (1,032) | |||
| Standard Deviation | 2.33 | |||
| Variance | 5.44 | |||
| Information Ratio | (0.13) | |||
| Jensen Alpha | (0.27) | |||
| Total Risk Alpha | (0.45) | |||
| Treynor Ratio | (0.43) | |||
| Maximum Drawdown | 18.45 | |||
| Value At Risk | (2.20) | |||
| Potential Upside | 2.92 | |||
| Skewness | (3.95) | |||
| Kurtosis | 25.74 |
Zimmer Biomet Holdings Backtested Returns
Zimmer Biomet Holdings shows Sharpe Ratio of -0.091, which attests that the company had a -0.091 % return per unit of risk over the last 3 months. Zimmer Biomet Holdings exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out Zimmer Biomet's Mean Deviation of 1.29, standard deviation of 2.33, and Market Risk Adjusted Performance of (0.42) to validate the risk estimate we provide. The firm maintains a market beta of 0.55, which attests to possible diversification benefits within a given portfolio. As returns on the market increase, Zimmer Biomet's returns are expected to increase less than the market. However, during the bear market, the loss of holding Zimmer Biomet is expected to be smaller as well. At this point, Zimmer Biomet Holdings has a negative expected return of -0.22%. Please make sure to check out Zimmer Biomet's treynor ratio, kurtosis, as well as the relationship between the Kurtosis and day typical price , to decide if Zimmer Biomet Holdings performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.19 |
Insignificant reverse predictability
Zimmer Biomet Holdings has insignificant reverse predictability. Overlapping area represents the amount of predictability between Zimmer Biomet time series from 28th of October 2025 to 12th of December 2025 and 12th of December 2025 to 26th of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Zimmer Biomet Holdings price movement. The serial correlation of -0.19 indicates that over 19.0% of current Zimmer Biomet price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.19 | |
| Spearman Rank Test | -0.45 | |
| Residual Average | 0.0 | |
| Price Variance | 4.79 |
Currently Active Assets on Macroaxis
When determining whether Zimmer Biomet Holdings offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Zimmer Biomet's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Zimmer Biomet Holdings Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Zimmer Biomet Holdings Stock:Check out Zimmer Biomet Correlation, Zimmer Biomet Volatility and Zimmer Biomet Alpha and Beta module to complement your research on Zimmer Biomet. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Zimmer Biomet technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.